HASTINGS DAVID C - Insider Non-Derivative Transactions at Arbutus Biopharma Corp (ABUS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Feb 14, 2025, HASTINGS DAVID C's relationship to Arbutus Biopharma Corp (ABUS) is Officer (Chief Financial Officer), and currently has 249,824 shares of Common Shares.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ABUS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

HASTINGS DAVID C - Insider Non-Derivative Transactions of ABUS Common Shares

HASTINGS DAVID C - Insider Non-Derivative Transactions at ABUS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Feb 15, 2025	Acquisition -- (Common Shares)	90100	0	249824
Feb 5, 2025	Sell -- (Common Shares)	22183	3.28	159724
Feb 3, 2024	Sell -- (Common Shares)	9593	2.31	181907
Feb 2, 2024	Acquisition -- (Common Shares)	112500	0	191500
Feb 2, 2023	Acquisition -- (Common Shares)	79000	0	79000